Vanguard Group Inc Immix Biopharma, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 698,537 shares of IMMX stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
698,537
Previous 698,537
-0.0%
Holding current value
$1.63 Million
Previous $1.6 Million
26.64%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IMMX
# of Institutions
25Shares Held
3.35MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY850KShares$1.99 Million0.49% of portfolio
-
Cable Car Capital LLC San Francisco, CA779KShares$1.82 Million1.49% of portfolio
-
Lynwood Capital Management Inc.405KShares$947,70011.13% of portfolio
-
Geode Capital Management, LLC Boston, MA161KShares$376,1360.0% of portfolio
-
Northern Trust Corp Chicago, IL95.3KShares$222,9130.0% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $32.5M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...